Type 2 Diabetes

ACP Defends Higher Blood Glucose Targets for Type 2 Diabetes

ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c ...

Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

An increasing number of studies support the use of continuous glucose monitoring in adult patients with T2D, and the observed benefits are likely to extend ...

Ask the Experts: Dr Goyal on SGLT2 Inhibitors

Dr Goyal from NYU Langone Health in New York City talks about SGLT2 inhibitors in the treatment of type 2 diabetes.

Addressing Psychological Insulin Resistance in Patients With Diabetes

Learn about strategies to reduce a patient's reluctance to initiate insulin therapy, a phenomenon called psychological insulin resistance.

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D

Results indicate that blood glucose monitoring should be conducted in hospitalized patients with diabetes.

Type 2 Diabetes and Antidepressant Drug Use: Is There a Causal Link?

Updated meta-analysis confirms the association between antidepressant drug (AD) use and incident diabetes. Future studies should be aimed at evaluating the effect of single AD ...

Video

Latest Headlines

Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes

Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes

A retrospective, observational study was conducted to assess outcomes in patients with type 2 diabetes treated with second-generation basal insulin analogs.

Travel Costs Are Considerable Part of T2DM Follow-Up Costs

Travel Costs Are Considerable Part of T2DM Follow-Up Costs

For patients with type 2 diabetes mellitus (T2DM), travel costs relating to hemoglobin A1c (HbA1c) screening constitute a substantial cost item, and self-monitoring can reduce costs.

Link Between Oral Diabetes Medications and Bullous Pemphigoid

Link Between Oral Diabetes Medications and Bullous Pemphigoid

Finnish investigators evaluated the link between diabetes medications other than DPP-4 inhibitors and the risk for BP.

β-Cell Function in Youth With Impaired Glucose Tolerance, T2D

β-Cell Function in Youth With Impaired Glucose Tolerance, T2D

Investigators examined whether β-cell function can be improved or preserved with antihyperglycemic agents in young patients.

1996 to 2013 Saw Large Increase in Diabetes Spending

1996 to 2013 Saw Large Increase in Diabetes Spending

Increased spending per encounter has been the biggest driver of overall rise in spending.

Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes

Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes

Investigators examined the efficacy of low-dose aspirin in cancer chemoprevention in patients with diabetes.

Diabetes Risk Associated With Cirrhosis, Not Chronic HCV Infection, in HIV+ Patients

Diabetes Risk Associated With Cirrhosis, Not Chronic HCV Infection, in HIV+ Patients

Cirrhosis is associated with an increased risk for diabetes mellitus among patients living with HIV.

Dulaglutide Effective for Patients With T2D, Moderate to Severe CKD

Dulaglutide Effective for Patients With T2D, Moderate to Severe CKD

Glycemic control with once-weekly dulaglutide was similar to that with insulin glargine in patients with type 2 diabetes and moderate to severe chronic kidney disease.

Risk for Type 2 Diabetes May Be Increased With Comorbid Depression, Anxiety

Risk for Type 2 Diabetes May Be Increased With Comorbid Depression, Anxiety

Investigators examined the association between risk for T2D and comorbid depressive and anxiety symptoms.

Cardiovascular Disease Risk Lower in Women With Type 2 Diabetes

Cardiovascular Disease Risk Lower in Women With Type 2 Diabetes

Investigators examined gender differences in baseline characteristics and outcomes in patients with t2d and ASCVD.

Sign Up for Free e-Newsletters



CME Focus